Brawn Biotech Limited (BOM:530207)
India · Delayed Price · Currency is INR 22.34
+1.04 (4.88%)
At close: Aug 18, 2026
Brawn Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 2.81 | 1.99 | 3.97 | 4.39 | 2.25 |
Cash & Short-Term Investments | 2.81 | 2.81 | 1.99 | 3.97 | 4.39 | 2.25 |
Cash Growth | 40.65% | 40.68% | -49.80% | -9.46% | 95.36% | -43.31% |
Accounts Receivable | - | 35.48 | 34.13 | 38.83 | 53.15 | 28.1 |
Other Receivables | - | - | 0.14 | 0.92 | 0.9 | 9.27 |
Receivables | - | 35.61 | 34.47 | 39.96 | 54.21 | 37.49 |
Inventory | - | 100.62 | 104.67 | 60.17 | 47.91 | 47.24 |
Prepaid Expenses | - | - | 1.84 | 2.25 | 2.57 | 3.25 |
Other Current Assets | - | 32.16 | 32.03 | 25.05 | 24.92 | 31.64 |
Total Current Assets | - | 171.2 | 175 | 131.4 | 133.99 | 121.87 |
Property, Plant & Equipment | - | 3.65 | 4.6 | 3.33 | 3.72 | 3.86 |
Long-Term Accounts Receivable | - | 19.19 | 20.14 | 6.59 | 5.99 | 5.88 |
Long-Term Deferred Tax Assets | - | 14.54 | 5.15 | 4.57 | 1.59 | 6.24 |
Other Long-Term Assets | - | - | - | 0 | - | - |
Total Assets | - | 208.57 | 204.89 | 145.89 | 145.3 | 137.85 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | - | 144.09 | 82.38 | 56.75 | 64.69 | 40.52 |
Accrued Expenses | - | - | 2.8 | 3.5 | 4.69 | 4.93 |
Current Income Taxes Payable | - | - | 0.26 | 0.25 | 1.51 | 7.22 |
Other Current Liabilities | - | 7.62 | 7.83 | 4.58 | 9.58 | 10.55 |
Total Current Liabilities | - | 151.7 | 93.27 | 65.08 | 80.47 | 63.21 |
Pension & Post-Retirement Benefits | - | - | 0.8 | 1.03 | 0.83 | 0.64 |
Other Long-Term Liabilities | - | 13.48 | 77.2 | 29.13 | 0.91 | 1.79 |
Total Liabilities | - | 165.18 | 171.27 | 95.24 | 82.21 | 65.64 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | - | 30 | 30 | 30 | 30 | 30 |
Additional Paid-In Capital | - | - | 15.2 | 15.2 | 15.2 | 15.2 |
Retained Earnings | - | - | -11.73 | 5.3 | 17.74 | 26.85 |
Comprehensive Income & Other | - | 13.39 | 0.15 | 0.15 | 0.15 | 0.15 |
Shareholders' Equity | 43.39 | 43.39 | 33.62 | 50.65 | 63.09 | 72.2 |
Total Liabilities & Equity | - | 208.57 | 204.89 | 145.89 | 145.3 | 137.85 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash (Debt) | 2.81 | 2.81 | 1.99 | 3.97 | 4.39 | 2.25 |
Net Cash Growth | 40.65% | 40.68% | -49.80% | -9.46% | 95.36% | -43.31% |
Net Cash Per Share | 0.95 | 0.97 | 0.66 | 1.32 | 1.46 | 0.75 |
Filing Date Shares Outstanding | 2.97 | 2.99 | 3 | 3 | 3 | 3 |
Total Common Shares Outstanding | 2.97 | 2.99 | 3 | 3 | 3 | 3 |
Working Capital | - | 19.5 | 81.74 | 66.32 | 53.53 | 58.66 |
Book Value Per Share | 14.50 | 14.50 | 11.21 | 16.88 | 21.03 | 24.07 |
Tangible Book Value | 43.39 | 43.39 | 33.62 | 50.65 | 63.09 | 72.2 |
Tangible Book Value Per Share | 14.50 | 14.50 | 11.21 | 16.88 | 21.03 | 24.07 |
Machinery | - | - | 10.24 | 7.83 | 7.71 | 6.75 |